<DOC>
	<DOCNO>NCT02052414</DOCNO>
	<brief_summary>To determine Gralise treat fibromyalgia pain : - efficacy - safety</brief_summary>
	<brief_title>Study Gralise Treat Fibromyalgia Patients</brief_title>
	<detailed_description>Subject must carry diagnosis fibromyalgia base American College Rheumatology ( ACR ) criteria fibromyalgia - Patient may gaba-analogue ( Pregabalin , trade name : lyrica , Gabapentin , trade name : Neurontin ) naïve , gaba analogue , discontinue lack efficacy . - Patient allergic reaction serious adverse reaction include study . - Patient start starter pack Gralise reach therapeutic dose 1800 mg per day end 2 week . - Drug take meal , day evening ; patient reach therapeutic dose 1800 mg , patient come visit , point PI evaluate patient may increase decrease dosage , patient may increase decrease dose medication /her discretion . - During study , patient total 5 visit , 4 duration patient Gralise , last visit taper medication . - During study , patient ask keep paper diary patient record numeric pain scale Fibromyalgia , time medication take , dose medication , side effect .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Subject must 18 year old . Subject carry Fibromyalgia diagnosis base American College Rheumatology criterion . Fibromyalgia patient gammaaminobutyric acid ( GABA ) analogue ( gabapentin pregabalin ) naïve , gammaaminobutyric acid ( GABA ) analogue , discontinue due side effect difficulty maintain dose schedule due multiple dos per day , currently immediate release gammaaminobutyric acidanalogue ( GABA ) . Able distinguish pain fibromyalgia pain source . ( subject rheumatic disease medical condition contribute symptom fibromyalgia exclude ) Subject pain score &gt; 4 Numeric pain rating scale ( NPRS ) Creatinine clearance &lt; 30mg/ml Pain Traumatic injury structural regional rheumatic disease Unstable medical psychiatric illness Lifetime history psychosis , hypomania , mania . Epilepsy , dementia Substance abuse last 6 month Suicidal tendency Pregnant breastfeed Not contraception childbearing age . ( Barrier method , oral contraception , hormone injection , surgical sterilization ) Subjects , opinion principle investigator , treatment refractory Treatment investigational drug within 30 day screen . Concomitant medication exclusion consist medication herbal agent Central Nervous System ( CNS ) effect exception episodic use sedate antihistamine Subject one additional class concomitant fibromyalgia medication i.e . nonselective serotonin reuptake inhibitor ( SSRI ) antidepressant , topicals , opioids .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>side effect</keyword>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
	<keyword>Gralise</keyword>
	<keyword>Fibromyalgia</keyword>
	<keyword>gabapentin</keyword>
</DOC>